A phase I pharmacokinetic study of belinostat in
patients with advanced cancers and varying
degrees of liver dysfunction
Naoko Takebe, National Cancer Institute, Bethesda
Jan H Beumer, UPMC Hillman Cancer Center
Shivaani Kummar, National Cancer Institute, Bethesda
Brian F Kiesel, UPMC Hillman Cancer Center
Afshin Dowlati, University Hospitals Seidman Cancer Center
Geraldine O Coyne, National Cancer Institute, Bethesda
Richard Piekarz, National Cancer Institute, Bethesda
Lawrence Rubinstein, National Cancer Institute, Bethesda
Laura K Fogli, National Cancer Institute, Bethesda
Bassel El-Rayes, Emory University
Journal Title: British Journal of Clinical Pharmacology
Volume: Volume 85, Number 11
Publisher: Wiley | 2019-11-01, Pages 2499-2511
Type of Work: Article | Final Publisher PDF
Publisher DOI: 10.1111/bcp.14054
Permanent URL: https://pid.emory.edu/ark:/25593/vh0dj
Final published version: http://dx.doi.org/10.1111/bcp.14054
Copyright information:
© 2019 The Authors.
This is an Open Access work distributed under the terms of the Creative
Commons Attribution-NonCommercial 4.0 International License
(https://creativecommons.org/licenses/by-nc/4.0/).
Accessed December 3, 2021 6:22 PM EST